Updated 2024 - 21 CFR 11, 50, 54, 56, 312, 314, ICH E2A, E6(R2) - Good Clinical Practice Handbook |
Clinical Master Reference Guide |
Medical Device Clinical with EU Directive |
ICH M3(R2) - Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals |
ICH S6 - Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals |
Updated 2024 - 21 CFR 50, 54, 56 - GCP Drug Approval Handbook |
21 CFR 54 - Financial Disclosure by Clinical Investigators |
ICH E2A - Clinical Safety Data Management: Definitions and Standards for Expedited Reporting |
ICH E8 - General Considerations for Clinical Studies |
ICH E6(R2) - Good Clinical Practice |
21 CFR 320 - Bioavailability and Bioequivalence Requirements |
ICH Q2(R2) and ICH Q14 Analytical Validation |
Parts 11, 606 and 1271 - Blood Cell & Tissue GMPs |
Parts 11, 606 and 1271 - Blood, Cell & Tissue with Annex 14 |
In Vitro Diagnostics Master Handbook |
VICH GL9 Animal GCP |
Title 21 CFR Parts 1 - End Nine Volume Set |
|
- Guaranteed Lowest Price
- Quantity Discounts Available
- Always Current, Up-To-Date
- Company Logos Available
- Special Customizations
- Pocket-sized 3.75" x 6.25"
- Prep for FDA & Client Audits
- Employee Training & Reference
- Promotional "giveaways"
- Tradeshows and meetings
-
|